Nobivac Ducat Suspension for Injection for cats 50 dose

Target species Cats. Indications for use Active immunisation of cats against feline viral rhinotracheitis (feline herpes virus type I) and feline calicivirus infections. Vaccination reduces clinical signs caused by these viral infections. Onset of immunity: 4 weeks. Duration of immunity: 1 year. Contraindications See section “Use during pregnancy or lactation”. Special warnings for each target species Vaccination at six weeks of age has been proven to be safe. Special precautions for use Vaccinate only healthy animals. Care should be taken that aerosol is not formed when vaccinating the cat as nasal or oral exposure could result in clinical respiratory signs including lethargy and malaise. For the same reason, the cat should be prevented from licking the injection site. Operator warnings In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions A slight transient, sometimes painful, swelling (≤ 5mm) may be observed at the site of injection for one day. A slight temporary rise in rectal temperature may occur, while occasionally transient lethargy may be observed during the first day after vaccination. In rare cases the vaccine may cause hypersensitivity reactions (pruritus, dyspnoea, vomiting, diarrhoea and collapse). Use during pregnancy, lactation or lay Do not use during pregnancy and lactation as the product has not been tested in pregnant and lactating queens. Interactions No information is available on the safety and efficacy from the concurrent use of this vaccine with any other, except Intervet’s vaccine containing rabies antigen, strain Pasteur RIV, where this product and the combined use is authorised. A decision to use Nobivac Ducat before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.